REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
05/24/2025
Back to search
Official data from USPTO
PATHOMICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PATHOMICS
ST13
US500000079176495Class
5, 35, 42
Filing
79176495
Registration
4962140
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
05/25/2025
Trademark type
Word
Nice classes
5, 35, 42
Filing date
01/22/2015
Registration date
05/24/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/07/2022
Last transaction
05/25/2025
Responsible office
United States Patent and Trademark Office
Status code
707
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
London, GB
Examiner
CROWLEY, SEAN
Law office
M70
Holders and representatives
Holders
HVIVO SERVICES LIMITED
Retroscreen Virology Limited
Representatives
Mainak H. Mehta Procopio, Cory, Hargreaves & Savitch LLP
Technical classification
Nice Classes
Class 5Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and medical compositions for human and/or veterinary usefor the treatment of dermatologicalcardiovascularhematologicalbonerespiratorycentral nervous systemendocrinologicalcirculatorygastroenterologicalhormonal and diabetic disorderscoughscoldsinfluenzaheadachesstomach and digestive disordersmuscular and/or rheumatic disordersanti-inflammatory agentsimmune system disorders and related diseasesallergic reactionsmetabolic disordersanti-infectivesoccular disordersfor use in oncology; vaccines for human beings and/or animals; adjuvants for use with vaccines; biological laboratory preparations for medical and/or veterinary purposesfor the treatment of dermatologicalcardiovascularhematologicalbonerespiratorycentral nervous systemendocrinologicalcirculatorygastroenterologicalhormonal and diabetic disorderscoughscoldsinfluenzaheadachesstomach and digestive disordersmuscular and/or rheumatic disordersanti-inflammatory agentsimmune system disorders and related diseasesallergic reactionsmetabolic disordersanti-infectivesoccular disordersfor use in oncology; chemical preparations and reagents for medicalpharmaceutical and veterinary purposesfor the treatment of dermatologicalcardiovascularhematologicalbonerespiratorycentral nervous systemendocrinologicalcirculatorygastroenterologicalhormonal and diabetic disorderscoughscoldsinfluenzaheadachesstomach and digestive disordersmuscular and/or rheumatic disordersanti-inflammatory agentsimmune system disorders and related diseasesallergic reactionsmetabolic disordersanti-infectivesoccular disordersfor use in oncology; viruses for the treatment of humans and/or animals; diagnostic preparations for medical purposes; in-vitro diagnostic preparations for medical purposes; in-vivo diagnostic preparations for medical purposes
Class 35
Investigation and research services relating to cost and business efficiencyall relating to pharmaceuticalsmedicinemedicinesvaccinessciencebacteriologytoxicologychemistryclinicologyoncologybiochemistry and biotechnology; systemization and compilation of medical information into computer databases; business statistical information all relating to pharmaceuticalsmedicinemedicinesvaccinessciencebacteriologytoxicologychemistryclinicologyoncologybiochemistry and biotechnology; registration services for diagnostic testing; product demonstration services in the field of diagnostic testing; computer database management servicesdatabase management services that allow for information storage in the fields of diagnostic testing and resultsdatabase management of medicalhospitalinsurance and billing records and information storage and retrieval services in the fields of diagnostic testing and preparations for the treatmentmonitoring or diagnosis of disease; trade information services in the fields of medicalhealthclinical care; database management of diagnostic testing and resultsdatabase management of medicalhospitalinsurance or billing records; collation and provision of business information for the purpose of providing referral services in the fields of medicalhealth or clinical care; collation and provision of business information in the fields of medicine and pharmacy; collation and provision of business information regarding medical and pharmaceutical testing procedures; collation and provision of business information regarding disease conditions and disease prevention; collation and provision of business information regarding medicalhospitalinsurance or billing records
Class 42
Medical research services; conducting clinical trials for others; medical research laboratory services; medical research laboratory services for the analysis of samples taken from patients; scientific analysis and research services; product development relating to pharmaceuticalsmedicinesmedicaments and veterinary products; medical and health care research servicesclinical testing servicesphysician testing services for assisting pharmacistspharmacy testing servicesmedical laboratory and testing services; medical research into the causes and treatment of influenza and the common cold
Publications
History of USPTO decisions and trademark events.
41 publications found
RNWL
INTERNATIONAL REGISTRATION RENEWED
09/12/2024
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
09/16/2023
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
08/08/2023
INPC
INVALIDATION PROCESSED
08/08/2023
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
07/07/2023
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
11/07/2022
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
11/07/2022
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
10/31/2022
PR71
POST REGISTRATION ACTION MAILED - SEC.71
05/24/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/23/2022
ES71
TEAS SECTION 71 RECEIVED
11/11/2021
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/24/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/09/2019
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
11/24/2016
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/16/2016
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/25/2016
FIMP
FINAL DISPOSITION PROCESSED
08/25/2016
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/24/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
05/24/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/08/2016
PUBO
PUBLISHED FOR OPPOSITION
03/08/2016
GPNX
NOTIFICATION PROCESSED BY IB
03/04/2016
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/17/2016
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/17/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/17/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/01/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/26/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/25/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/25/2016
ALIE
ASSIGNED TO LIE
01/25/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/12/2016
RFNT
REFUSAL PROCESSED BY IB
12/31/2015
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/04/2015
RFRR
REFUSAL PROCESSED BY MPU
12/04/2015
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/02/2015
CNRT
NON-FINAL ACTION WRITTEN
12/01/2015
MAFR
APPLICATION FILING RECEIPT MAILED
11/25/2015
DOCK
ASSIGNED TO EXAMINER
11/21/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/21/2015
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/19/2015
Continuous trademark protection
Get notified about every new filing that threatens PATHOMICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.